tetano
Editor, Senior Moderator
J Clin Med
. 2022 Sep 3;11(17):5213.
doi: 10.3390/jcm11175213.
Impact of COVID-19 on Neuropsychiatric Disorders
Niloufar Zia[SUP] 1 [/SUP], Parsa Ravanfar[SUP] 2 [/SUP], Sepideh Allahdadian[SUP] 3 [/SUP], Mehdi Ghasemi[SUP] 4 [/SUP]
Affiliations
Abstract
Since the Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many studies have shown that besides common COVID-19 symptoms, patients may develop various neuropsychiatric conditions including anxiety, mood disorders, psychosis, neurodegenerative diseases (e.g., dementia), insomnia, and even substance abuse disorders. COVID-19 can also worsen the patients underlying neuropsychiatric and neurodevelopmental conditions during or after the system phase of disease. In this review, we discuss the impact of SARS-CoV-2 infection on development or status of neuropsychiatric conditions during or following COVID-19.
Keywords: coronavirus disease 2019 (COVID-19); neurodegenerative diseases; neurodevelopmental diseases; neuropsychiatry; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
. 2022 Sep 3;11(17):5213.
doi: 10.3390/jcm11175213.
Impact of COVID-19 on Neuropsychiatric Disorders
Niloufar Zia[SUP] 1 [/SUP], Parsa Ravanfar[SUP] 2 [/SUP], Sepideh Allahdadian[SUP] 3 [/SUP], Mehdi Ghasemi[SUP] 4 [/SUP]
Affiliations
- PMID: 36079143
- DOI: 10.3390/jcm11175213
Abstract
Since the Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many studies have shown that besides common COVID-19 symptoms, patients may develop various neuropsychiatric conditions including anxiety, mood disorders, psychosis, neurodegenerative diseases (e.g., dementia), insomnia, and even substance abuse disorders. COVID-19 can also worsen the patients underlying neuropsychiatric and neurodevelopmental conditions during or after the system phase of disease. In this review, we discuss the impact of SARS-CoV-2 infection on development or status of neuropsychiatric conditions during or following COVID-19.
Keywords: coronavirus disease 2019 (COVID-19); neurodegenerative diseases; neurodevelopmental diseases; neuropsychiatry; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).